UBS Group’s Zymergen Inc. Common Stock ZY Stock Holding History

UBS Group’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,406	Closed	-$73K	–	11952
2022 Q3	$73K	Buy	26,406 +19,810	+300%	+$48.1K	﹤0.01%	6008
2022 Q2	$8K	Sell	6,596 -11,276	-63%	-$18.9K	﹤0.01%	8424
2022 Q1	$51K	Sell	17,872 -67,035	-79%	-$285K	﹤0.01%	6489
2021 Q4	$568K	Buy	84,907 +71,196	+519%	+$691K	﹤0.01%	4874
2021 Q3	$181K	Sell	13,711 -33,697	-71%	-$715K	﹤0.01%	5394
2021 Q2	$1.9M	Buy	+47,408	New	+$1.87M	﹤0.01%	3622

UBS Group's ZY Position: Q4 2022 in Review

UBS Group sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 26,406 shares — an estimated $73K sold.

UBS Group first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $1.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

UBS Group reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 26,406 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $73K.
UBS Group first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
UBS Group's Zymergen Inc. Common Stock position peaked at $1.9M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.